149 related articles for article (PubMed ID: 17116296)
41. Viral-vectored boosting of OmcB or CPAF-specific T cell responses fail to enhance protection from Chlamydia muridarum in infection immune mice and elicits a non-protective CD8-dominant response in naïve mice.
Poston TB; Girardi J; Grace Polson A; Bhardwaj A; Yount KS; Jaras Salas I; Trim LK; Li Y; O'Connell CM; Leahy D; Harris JM; Beagley KW; Goonetilleke N; Darville T
Mucosal Immunol; 2024 Jul; ():. PubMed ID: 38969067
[TBL] [Abstract][Full Text] [Related]
42. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
Gieni RS; Yang X; Kelso A; Hayglass KT
Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
[TBL] [Abstract][Full Text] [Related]
43. The Chlamydia-Secreted Protease CPAF Promotes Chlamydial Survival in the Mouse Lower Genital Tract.
Yang Z; Tang L; Shao L; Zhang Y; Zhang T; Schenken R; Valdivia R; Zhong G
Infect Immun; 2016 Sep; 84(9):2697-702. PubMed ID: 27382018
[TBL] [Abstract][Full Text] [Related]
44. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
45. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium.
Bry L; Brigl M; Brenner MB
Infect Immun; 2006 Jan; 74(1):673-81. PubMed ID: 16369024
[TBL] [Abstract][Full Text] [Related]
46. Chlamydia muridarum infection-induced destruction of male germ cells and sertoli cells is partially prevented by Chlamydia major outer membrane protein-specific immune CD4 cells.
Sobinoff AP; Dando SJ; Redgrove KA; Sutherland JM; Stanger SJ; Armitage CW; Timms P; McLaughlin EA; Beagley KW
Biol Reprod; 2015 Jan; 92(1):27. PubMed ID: 25472923
[TBL] [Abstract][Full Text] [Related]
47. NK cells promote type 1 T cell immunity through modulating the function of dendritic cells during intracellular bacterial infection.
Jiao L; Gao X; Joyee AG; Zhao L; Qiu H; Yang M; Fan Y; Wang S; Yang X
J Immunol; 2011 Jul; 187(1):401-11. PubMed ID: 21642541
[TBL] [Abstract][Full Text] [Related]
48. Comparative evaluation of the protective efficacy of two formulations of a recombinant Chlamydia abortus subunit candidate vaccine in a mouse model.
Pan Q; Pais R; Ohandjo A; He C; He Q; Omosun Y; Igietseme JU; Eko FO
Vaccine; 2015 Apr; 33(15):1865-72. PubMed ID: 25698486
[TBL] [Abstract][Full Text] [Related]
49. CPAF selectively degrades chlamydial T cell antigens for inhibiting antigen presentation.
Zhang Y; Zhong G; Cai H; Chen S; Sun D; Zhang D; He Y
J Infect Dev Ctries; 2017 Dec; 11(11):868-875. PubMed ID: 31618186
[TBL] [Abstract][Full Text] [Related]
50. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
[TBL] [Abstract][Full Text] [Related]
51. A TriAdj-Adjuvanted
Proctor J; Stadler M; Cortes LM; Brodsky D; Poisson L; Gerdts V; Smirnov AI; Smirnova TI; Barua S; Leahy D; Beagley KW; Harris JM; Darville T; Käser T
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675805
[No Abstract] [Full Text] [Related]
52. Mice deficient in MyD88 Develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection.
Chen L; Lei L; Chang X; Li Z; Lu C; Zhang X; Wu Y; Yeh IT; Zhong G
J Immunol; 2010 Mar; 184(5):2602-10. PubMed ID: 20124098
[TBL] [Abstract][Full Text] [Related]
53. Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies.
Goedert S; Germann T; Hoehn P; Koelsch S; Palm N; Rüde E; Schmitt E
J Immunol; 1996 Jul; 157(2):566-73. PubMed ID: 8752903
[TBL] [Abstract][Full Text] [Related]
54. Protective anti-outer membrane protein immunity against Pasteurella pneumotropica infection of mice.
See SB; Thomas WR
Microbes Infect; 2013 Jun; 15(6-7):470-9. PubMed ID: 23624107
[TBL] [Abstract][Full Text] [Related]
55. Cleavage of the NF-κB family protein p65/RelA by the chlamydial protease-like activity factor (CPAF) impairs proinflammatory signaling in cells infected with Chlamydiae.
Christian J; Vier J; Paschen SA; Häcker G
J Biol Chem; 2010 Dec; 285(53):41320-7. PubMed ID: 21041296
[TBL] [Abstract][Full Text] [Related]
56. Immunization with dendritic cells pulsed ex vivo with recombinant chlamydial protease-like activity factor induces protective immunity against genital chlamydiamuridarum challenge.
Li W; Murthy AK; Chaganty BK; Guentzel MN; Seshu J; Chambers JP; Zhong G; Arulanandam BP
Front Immunol; 2011; 2():73. PubMed ID: 22566862
[TBL] [Abstract][Full Text] [Related]
57. Neutralizing antichlamydial activity of complement by chlamydia-secreted protease CPAF.
Yang Z; Tang L; Zhou Z; Zhong G
Microbes Infect; 2016 Nov; 18(11):669-674. PubMed ID: 27436813
[TBL] [Abstract][Full Text] [Related]
58. Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species.
Dong F; Zhong Y; Arulanandam B; Zhong G
Infect Immun; 2005 Mar; 73(3):1868-72. PubMed ID: 15731091
[TBL] [Abstract][Full Text] [Related]
59. Cleavage-dependent activation of a chlamydia-secreted protease.
Dong F; Pirbhai M; Zhong Y; Zhong G
Mol Microbiol; 2004 Jun; 52(5):1487-94. PubMed ID: 15165249
[TBL] [Abstract][Full Text] [Related]
60. A path forward for the chlamydial virulence factor CPAF.
A Conrad T; Yang Z; Ojcius D; Zhong G
Microbes Infect; 2013 Dec; 15(14-15):1026-32. PubMed ID: 24141088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
